[EN] NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS<br/>[FR] INHIBITEURS DE TRANSPORT DE POLYAMINE À BASE DE NON-POLYAMINE ET LEUR UTILISATION DANS LE TRAITEMENT DE CANCERS HUMAINS
申请人:UNIV CENTRAL FLORIDA RES FOUND INC
公开号:WO2020033944A3
公开(公告)日:2020-03-26
NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS
申请人:University of Central Florida
Research Foundation, Inc.
公开号:EP3833352A2
公开(公告)日:2021-06-16
Mild, metal-free synthesis of 2-substituted quinazolinones from imidates and methyl 2-aminobenzoates or 2-aminobenzamides
Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function
作者:Aiste Dobrovolskaite、Holly Moots、Mukund P. Tantak、Kunal Shah、Jenna Thomas、Sharifa Dinara、Chelsea Massaro、Paul M. Hershberger、Patrick R. Maloney、Satyamaheshwar Peddibhotla、Eliot Sugarman、Sally Litherland、Juan Pablo Arnoletti、Rajiv Kumar Jha、David Levens、Otto Phanstiel
DOI:10.1021/acs.jmedchem.2c01350
日期:2022.11.24
Polyaminebiosynthesis is regulated by ornithine decarboxylase (ODC), which is transcriptionally activated by c-Myc. A large library was screened to find molecules that potentiate the ODC inhibitor, difluoromethylornithine (DFMO). Anthranilic acid derivatives were identified as DFMO adjunct agents. Further studies identified the far upstream binding protein 1 (FUBP1) as the target of lead compound